SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-07-008740
Filing Date
2007-11-08
Accepted
2007-11-08 15:33:01
Documents
6
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2180729z10-q.htm 10-Q 318684
2 EXHIBIT 10.5 a2180729zex-10_5.htm EX-10.5 14687
3 EXHIBIT 31.1 a2180729zex-31_1.htm EX-31.1 6324
4 EXHIBIT 31.2 a2180729zex-31_2.htm EX-31.2 6367
5 EXHIBIT 32.1 a2180729zex-32_1.htm EX-32.1 2856
6 EXHIBIT 32.2 a2180729zex-32_2.htm EX-32.2 2860
  Complete submission text file 0001047469-07-008740.txt   353329
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 071225554
SIC: 2835 In Vitro & In Vivo Diagnostic Substances